Teleflex Incorporated (TFX)
NYSE: TFX · IEX Real-Time Price · USD
208.48
+1.77 (0.86%)
Apr 29, 2024, 4:00 PM EDT - Market closed

Teleflex Revenue

In the year 2023, Teleflex had annual revenue of $2.97B with 6.57% growth. Revenue in the quarter ending December 31, 2023 was $773.91M with 2.10% year-over-year growth.

Revenue (ttm)
$2.97B
Revenue Growth
+6.57%
P/S Ratio
3.30
Revenue / Employee
$205,137
Employees
14,500
Market Cap
9.81B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.97B183.45M6.57%
Dec 31, 20222.79B-18.52M-0.66%
Dec 31, 20212.81B272.41M10.74%
Dec 31, 20202.54B-58.21M-2.24%
Dec 31, 20192.60B146.98M6.00%
Dec 31, 20182.45B302.08M14.07%
Dec 31, 20172.15B278.28M14.90%
Dec 31, 20161.87B58.34M3.22%
Dec 31, 20151.81B-30.14M-1.64%
Dec 31, 20141.84B143.56M8.46%
Dec 31, 20131.70B145.26M9.37%
Dec 31, 20121.55B58.48M3.92%
Dec 31, 20111.49B94.81M6.78%
Dec 31, 20101.40B-37.16M-2.59%
Dec 31, 20091.43B-477.20M-24.96%
Dec 31, 20081.91B337.00M21.40%
Dec 31, 20071.58B-115.73M-6.84%
Dec 31, 20061.69B128.94M8.26%
Dec 25, 20051.56B-828.54M-34.66%
Dec 26, 20042.39B329.52M15.99%
Dec 28, 20032.06B98.03M4.99%
Dec 29, 20021.96B57.86M3.04%
Dec 30, 20011.91B140.52M7.96%
Dec 31, 20001.76B163.41M10.21%
Dec 26, 19991.60B163.49M11.37%
Dec 27, 19981.44B291.81M25.47%
Dec 28, 19971.15B214.59M23.04%
Dec 29, 1996931.18M18.49M2.03%
Dec 31, 1995912.69M100.02M12.31%
Dec 25, 1994812.67M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Tenet Healthcare 20.56B
Universal Health Services 14.28B
Henry Schein 12.34B
Smith & Nephew 5.55B
Catalent 4.10B
AptarGroup 3.54B
Exact Sciences 2.50B
Qiagen 1.97B
Revenue Rankings